Exchange: NASDAQ·Updated 07:44 PM EDT
SLXN logo

SLXN Silexion Therapeutics Ltd

$0.3518
$0.0002
(0.06%)
Today
Closed $0.3518
$0.0004
(0.11%)
After Hours
Reported EarningsAug 14
Mkt Cap$2.02M
Vol204,055.00

About SLXN

Silexion Therapeutics Corp. is a clinical-stage biotechnology company, which engages in the discovery and development of treatments for KRAS-driven cancers. The company was founded on November 30, 2008 and is headquartered in in Modiin, Israel.
63

Bullish Sentiment

How do you feel about SLXN?

Advertisement|Remove ads.